●
AVTX
Avalo Therapeutics, Inc.
$2.07M
Single sell
Discretionary Insider Activity
Date:
06/12/2023
Insiders:
Caissa Capital Management ltd., a 10%+ owner, and 1 others
Prior trend:
16 months of no clear discretionary insider activity

Summary

A $2.07M single sell for Avalo Therapeutics, Inc. (AVTX) on 06/12/2023 after 16 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $64K 06/14/2023 Caissa Capital Management ltd. A 10%+ owner 0001929354-23-000014
● Buy $32K 06/20/2023 Caissa Capital Management ltd. A 10%+ owner 0001929354-23-000015
● Sell $2.17M 06/28/2023 ARMISTICE CAPITAL, LLC + 1 A 10%+ owner 0000899243-23-016659

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $9K 06/12/2023 Caissa Capital Management ltd. Common Stock Discretionary Purchase
● Buy $33K 06/13/2023 Caissa Capital Management ltd. Common Stock Discretionary Purchase
● Buy $21K 06/14/2023 Caissa Capital Management ltd. Common Stock Discretionary Purchase
● Buy $12K 06/15/2023 Caissa Capital Management ltd. Common Stock Discretionary Purchase
● Buy $12K 06/16/2023 Caissa Capital Management ltd. Common Stock Discretionary Purchase
● Buy $8K 06/20/2023 Caissa Capital Management ltd. Common Stock Discretionary Purchase
● Sell $1.68M 06/26/2023 ARMISTICE CAPITAL, LLC Common Stock Discretionary Sale
● Sell $487K 06/27/2023 ARMISTICE CAPITAL, LLC Common Stock Discretionary Sale

Stats

Prior max multiple:
3.0
Prior median multiple:
9.9

Metadata

Signal ID:
INsklt3xwD2HFCW2
Detected on:
07/15/2023